They prepared a TRPP2 siRNA-exosome complex and designed experiments to demonstrate that free TRPP2 siRNA and the TRPP2 siRNA-exosome complex can downregulate TRPP2 in cancer cells, inhibit EMT, and significantly weaken tumor cell invasion and growth. Here, PKD2 is linked to cancer.